Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infection and venous thrombosis.

Joseph Emmerich1

  • 1Service de Médecine Vasculaire et HTA, Centre Claude Bernard de recherche sur les maladies vasculaires, INSERM U428, University Paris 5, Paris, France. joseph.emmerich@egp.ap-hop-paris.fr

Pathophysiology of Haemostasis and Thrombosis
|September 19, 2003
PubMed
Summary

Chlamydia pneumoniae infection may increase the risk of venous thromboembolism (VTE). This study found higher antibody levels in VTE patients, suggesting a potential link between this infection and blood clot formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soluble CD146 reflects altered endothelial and metabolic homeostasis in peripheral artery disease.

Angiogenesis·2026
Same author

Endocarditis Due to <i>Scedosporium</i> spp and <i>Lomentospora prolificans</i>: Case Series and Literature Review.

Open forum infectious diseases·2026
Same author

Differential presence of neutrophil extracellular traps in serum vs plasma of patients with critical limb-threatening ischemia.

Research and practice in thrombosis and haemostasis·2026
Same author

ESC/EAS 2025 dyslipidaemia guidelines update: Don't get left behind!

Archives of cardiovascular diseases·2025
Same author

Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes.

Blood·2025
Same author

Effects on mortality of extended versus short-term anticoagulation in venous thromboembolism: a systematic review and meta-analysis of randomized trials.

Research and practice in thrombosis and haemostasis·2025

Area of Science:

  • Infectious Diseases
  • Cardiovascular Medicine
  • Hematology

Background:

  • Chlamydia pneumoniae infection is a known risk factor for atherosclerosis.
  • The potential association between Chlamydia pneumoniae and venous thromboembolism (VTE) has not been previously investigated.
  • Understanding novel risk factors for VTE is crucial for prevention and management.

Purpose of the Study:

  • To investigate the association between Chlamydia pneumoniae infection and the occurrence of VTE.
  • To determine if circulating anti-C. pneumoniae antibody levels are elevated in patients with VTE.

Main Methods:

  • A case-control study was conducted comparing patients with VTE to a control group.
  • Circulating specific IgG antibody titers against Chlamydia pneumoniae were measured in all participants.

Related Experiment Videos

  • Statistical analysis, including odds ratios and confidence intervals, was used to assess the association, adjusting for genetic risk factors (Factor V Leiden and Factor II G20210A mutations).

    • Main Results:

    • A significantly higher prevalence of specific IgG titers (≥256) against Chlamydia pneumoniae was observed in VTE patients (54%) compared to controls (15.9%) (p<0.0001).
    • The crude odds ratio for VTE associated with elevated C. pneumoniae antibodies was 6.2 (95% CI, 3.8-10.1).
    • After adjusting for common thrombophilia mutations, the odds ratio increased to 7.7 (95% CI, 4.5-13.2).

    Conclusions:

    • The study suggests a potential association between Chlamydia pneumoniae infection and an increased risk of venous thromboembolism.
    • Elevated antibody levels indicate a possible role of this infection in VTE pathogenesis.
    • Further validation through larger case-control or prospective studies is warranted to confirm these findings.